A recent study showed that women who
had been taking calcium-channel blockers to treat high blood pressure
for more than 10 years were 2.5 times more likely to have breast cancer,
compared with women who did not use blood pressure medication, or who
used other types. However, it should be cautioned that the study is
preliminary and further studies are needed before recommendations are
made. So, continue taking your medications but the findings are interesting, to say the least.
About 1,900 women with breast cancer
participated in the study, as well as about 850 women with no cancer who
served as the control group. The researchers didn’t find a link
between an increased breast cancer risk and other types of high blood
pressure medications, such as beta-blockers or diuretics, according to
the study published in the Journal of the American Medical Association.
Medications for treating high blood pressure, called antihypertensives,
are the most commonly prescribed drugs in the United States. An
estimated 678 million prescriptions were filled in 2010, including 98
million prescriptions for calcium-channel blockers, the researchers
said.
A professor in epidemiology at Boston
University noted in an editorial that this is not the first time that
the specter of a link between [calcium-channel blockers] and breast
cancer risks have risen.
But previous studies had yielded mixed
results. They did not have a sufficient number of participants, or did
not investigate long-term use of antihypertensives.
The professor said that the study “is a very well-done study and
therefore there appears to be a hypothesis that now needs to be
confirmed.” She also said that the study isn’t at a stage where women
should be panicking about taking these drugs. The study shows a link,
but does not prove a cause-and-effect relationship between the drugs and
breast cancer.
Calcium-channel blockers work by
slowing the movement of calcium into muscle cells, which dilates blood
vessels, reduces the force of the heart’s contractions and slows the
heartbeat. Doctors may consider how the patient responds to different
medications, and their other conditions. There are people who don’t
tolerate some of the other classes of medications, and respond well to calcium-channel blockers.
However, if patients are concerned, and
because there are several classes of hypertensives, patients can
certainly discuss their options with their physician, and look into
alternative blood pressure treatments. Be sure to discuss your concerns
with your doctor.
The next step in the current research
would be to look at more groups of people who take blood pressure
medications, as well as to better understand the underlying mechanism by
which the calcium-channel blockers may affect cancer risk, the
researchers said.
Antihypertensives only came on the market in the past few decades, so there has not been sufficient number of long-term users of these medications.
We are now getting to the point where
we have enough people who’ve been exposed to these medications for long
periods of time to evaluate such long-term potential risks.
No comments:
Post a Comment